Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BerGenBio AGM Information 2018

May 14, 2018

3555_rns_2018-05-14_3e770e40-1cd5-4dac-9a75-6d44c17a688e.html

AGM Information

Open in viewer

Opens in your device viewer

BerGenBio ASA: Annual General Meeting

BerGenBio ASA: Annual General Meeting

Bergen, Norway, 14 May 2018 - The Annual General Meeting of BerGenBio ASA was

held at Møllendalsbakken 9, 5009 Bergen, on 14 May 2018.

All proposals were resolved as presented in the notice convening the annual

general meeting distributed on 23 April 2018, as further set out in the minutes

from the annual general meeting attached hereto.

For further information, please contact:

Richard Godfrey

CEO, BerGenBio ASA

[email protected]

Rune Skeie

CFO, BerGenBio ASA

[email protected]

+47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not

historical facts, but are based upon various assumptions, many of which are

based, in turn, upon further assumptions. These assumptions are inherently

subject to significant known and unknown risks, uncertainties and other

important factors. Such risks, uncertainties, contingencies and other important

factors could cause actual events to differ materially from the expectations

expressed or implied in this announcement by such forward-looking statements.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.